• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Celanese Corporation Reports Second Quarter Earnings

    8/11/25 4:05:00 PM ET
    $CE
    Major Chemicals
    Industrials
    Get the next $CE alert in real time by email

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today reported second quarter 2025 U.S. GAAP diluted earnings per share of $1.90 and adjusted earnings per share of $1.44. The Company generated net sales of $2.5 billion in the second quarter, a 6 percent increase from the previous quarter driven by increases of 4 percent in volume and 3 percent in currency, with a small offset in price. Most end-markets continued to be challenged in the second quarter, and Celanese remained focused on driving self-help measures to advance the strategic priorities of increasing cash to deleverage the balance sheet, intensifying cost improvements, and driving top-line growth through differentiated business models. These actions supported the Company's ability to deliver second quarter consolidated operating profit of $233 million, adjusted EBIT of $344 million, and operating EBITDA of $532 million at margins of 9, 14, and 21 percent, respectively. The results represented sequential improvement across all of these profitability metrics.

    The difference between U.S. GAAP diluted earnings per share and adjusted earnings per share in the second quarter was due to tax benefit of $77 million offset by Certain Items totaling $42 million1.

    Celanese implemented multiple new actions, in addition to previously announced plans, to deliver consistent earnings growth and increase cash generation to deleverage the balance sheet. These actions include the following:

    • Utilized prepayment flexibility in the capital structure to fully repay the $200 million balance on the delayed draw term loan that was originally due in the first quarter of 2026. Additionally, since the close of the second quarter, the Company paid down an incremental $150 million of the five-year term senior unsecured loan due in 2027.
    • Completed a new credit agreement and a new $1.75 billion senior unsecured revolving credit facility, which further reinforces the Company's strong liquidity position through 2030.
    • Progressed to the second round of the Micromax® divestiture process, garnering significant interest from a large and diverse set of potential buyers.
    • Announced the intention to exit the Sempach, Switzerland Elotex® redispersible powders location and the Engineered Materials Vamac® location at Sarnia (St. Clair) Canada. These actions are targeted to deliver approximately $5 to $10 million in cost savings in 2026. Activities from both sites will be absorbed into the Company's existing infrastructure.
    ____________________________

    1

    Mainly driven by exit and shutdown costs related to business optimization projects.

    "Since the start of 2025, we have been clear that cash generation is our number one priority, and I want to thank our teams for their focus and dedication in helping us achieve over $300 million of free cash flow in the quarter," said Scott Richardson, president and chief executive officer. "We anticipated the possibility of a challenging demand environment throughout the year and have emphasized the importance of cash generation, which has enabled us to pay off our delayed draw term loan," continued Richardson. "We are also pleased that the deliberate actions we took drove earnings results for us this quarter, especially in the Engineered Materials business. We are confident that our action plans will continue to drive value. However, the demand environment does not seem to be improving, so our focus remains unchanged. We continue to take aggressive actions to generate cash, reduce costs, and drive growth through our two highly differentiated business models."

    Second Quarter 2025 Financial Highlights:

     

    Three Months Ended

     

    June 30,

    2025

     

    March 31,

    2025

     

    June 30,

    2024

     

    (unaudited)

     

    (In $ millions, except per share data)

    Net Sales

     

     

     

     

     

    Engineered Materials

     

    1,442

     

     

     

    1,287

     

     

     

    1,467

     

    Acetyl Chain

     

    1,115

     

     

     

    1,116

     

     

     

    1,202

     

    Intersegment Eliminations

     

    (25

    )

     

     

    (14

    )

     

     

    (18

    )

    Total

     

    2,532

     

     

     

    2,389

     

     

     

    2,651

     

     

     

     

     

     

     

    Operating Profit (Loss)

     

     

     

     

     

    Engineered Materials

     

    165

     

     

     

    96

     

     

     

    138

     

    Acetyl Chain

     

    154

     

     

     

    162

     

     

     

    242

     

    Other Activities

     

    (86

    )

     

     

    (90

    )

     

     

    (130

    )

    Total

     

    233

     

     

     

    168

     

     

     

    250

     

     

     

     

     

     

     

    Net Earnings (Loss)

     

    202

     

     

     

    (17

    )

     

     

    153

     

     

     

     

     

     

     

    Adjusted EBIT(1)

     

     

     

     

     

    Engineered Materials

     

    214

     

     

     

    126

     

     

     

    265

     

    Acetyl Chain

     

    196

     

     

     

    168

     

     

     

    277

     

    Other Activities

     

    (66

    )

     

     

    (60

    )

     

     

    (91

    )

    Total

     

    344

     

     

     

    234

     

     

     

    451

     

     

     

     

     

     

     

    Equity Earnings and Dividend Income, Other Income (Expense)

     

     

     

     

     

    Engineered Materials

     

    25

     

     

     

    17

     

     

     

    49

     

    Acetyl Chain

     

    43

     

     

     

    3

     

     

     

    33

     

     

     

     

     

     

     

    Operating EBITDA(1)

     

    532

     

     

     

    414

     

     

     

    632

     

    Diluted EPS - continuing operations

    $

    1.90

     

     

    $

    (0.15

    )

     

    $

    1.42

     

    Diluted EPS - total

    $

    1.81

     

     

    $

    (0.19

    )

     

    $

    1.41

     

    Adjusted EPS(1)

    $

    1.44

     

     

    $

    0.57

     

     

    $

    2.38

     

     

     

     

     

     

     

    Net cash provided by (used in) investing activities

     

    (88

    )

     

     

    (98

    )

     

     

    (91

    )

    Net cash provided by (used in) financing activities

     

    (116

    )

     

     

    45

     

     

     

    (489

    )

    Net cash provided by (used in) operating activities

     

    410

     

     

     

    37

     

     

     

    292

     

    Free cash flow(1)

     

    311

     

     

     

    (73

    )

     

     

    173

     

    ____________________________

    (1)

    See "Non-US GAAP Financial Measures" below.

    Second Quarter Business Segment Overview

    Acetyl Chain

    The Acetyl Chain delivered second quarter net sales of $1.1 billion, attributable to sequential declines of 1 percent in volume and 2 percent in price that were offset by an increase in currency. The overall demand environment for the business remained challenged. The business faced headwinds in acetate tow and the vinyls business. In acetate tow, sales were slower than anticipated, and customer inventory rebalancing from the first quarter did not abate as expected. In the vinyls business, pricing and volume actions the Company took did not fully materialize amid slowing demand. Acetyl Chain delivered second quarter operating profit of $154 million, adjusted EBIT of $196 million, and operating EBITDA of $260 million at margins of 14, 18, and 23 percent, respectively. In Asia, the Acetyl Chain was impacted by continued demand weakness across key end-markets like paints, coatings, and construction that was amplified by over-supply in China. In the Western Hemisphere, general demand sluggishness across these same key end-markets impacted the quarter. The Acetyl Chain continued to take actions to drive consistency of earnings, including optimizing production at low-cost, U.S. based assets, reducing operating rates at higher cost sites, and reducing global distribution costs to align with the demand environment.

    Engineered Materials

    Engineered Materials reported second quarter net sales of $1.4 billion, representing an increase of 12 percent compared to the previous quarter, consisting of a 9 percent increase in volume and a 3 percent increase due to currency. Volumes in the quarter were slightly improved from the previous quarter due to the easing of automotive destocking in Europe, but still below normal levels. Order books began to weaken in June, especially in Europe and China, and have continued to do so into the early stages of the third quarter. Engineered Materials reported second quarter operating profit of $165 million, adjusted EBIT of $214 million, and operating EBITDA of $326 million, with margins of 11, 15, and 23 percent, respectively. The strong business results were driven by deliberate actions taken earlier in the year to accelerate earnings improvement and offset headwinds related to a weaker demand environment and trade flow challenges. Product mix was favorable due to product positioned globally to capture available demand. Mix was also supported by continued focus on High Impact Programs (HIPs), higher margin projects that emphasize specialty product offerings. In terms of cash generation, Engineered Materials has continued to progress against the previously stated goal of reducing inventory by approximately $100 million in 2025.

    Cash Flow and Tax

    Celanese reported second quarter operating cash flow of $410 million and free cash flow of $311 million, which included cash capital expenditures of $93 million. Second quarter operating cash flow and free cash flow results were mainly driven by sequential earnings improvement and continued progress against inventory reduction goals in Engineered Materials.

    The effective U.S. GAAP income tax rate for the three months ended June 30, 2025 was a benefit of 57 percent compared with an expense of 16 percent for the same period in 2024. The effective income tax rate for the current period is lower compared to the same period in 2024, primarily due to a net deferred tax benefit related to the relocation of certain intangible assets among wholly owned foreign affiliates as part of continued integration of global principal operations, and a tax benefit related to the resolution of a review of prior year tax matters.

    Outlook

    Celanese expects a softening demand environment across most key end-markets in the second half of the year. The Company anticipates slowing demand will partially offset the benefits from the cost reduction actions that are expected to be realized in the third quarter. Additionally, Celanese anticipates an approximate $25 million negative sequential impact to earnings due to ongoing inventory reduction efforts.

    "In this low-demand environment that remains uncertain, we will continue to emphasize cash flow. While our order books are developing at a slower pace so far compared to last quarter, we remain agile and are poised to pivot our operations to align with available demand," said Scott Richardson. "Considering these dynamics, and our intention to release cash through inventory reduction, we anticipate third quarter adjusted earnings per share to be $1.10 to $1.40. Given the actions we are taking, our expectation remains to deliver $700 to $800 million of free cash flow in 2025."

    "This is a challenging macro, and our teams are exhibiting resilience to continually find new areas to create value," continued Richardson. "We are relentlessly focused on identifying additional actions and we continue to take steps to stabilize the business, right size our cost structure, and position our company for long-term value creation."

    Reconciliations of forecasted non-GAAP measures such as adjusted earnings per share, adjusted EBIT, operating EBITDA or free cash flow to the equivalent U.S. GAAP measures (diluted earnings per share, net earnings (loss) attributable to Celanese Corporation and net cash provided by (used in) operations, respectively), are not available without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, and other items is not practical. For more information, see "Non-GAAP Financial Measures" below.

    The Company's prepared remarks related to the second quarter will be posted on its website at investors.celanese.com under Financial Information/Financial Document Library on August 11, 2025. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on our investor relations website under Financial Information/Non-GAAP Financial Measures. See also "Non-GAAP Financial Measures" below.

    Celanese Corporation is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese Corporation is a Fortune 500 company that employs more than 11,000 employees worldwide with 2024 net sales of $10.3 billion.

    Forward-Looking Statements

    This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, planned cost reductions, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: the ability to successfully achieve planned cost reductions; changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, carbon monoxide, wood pulp, hexamethylene diamine, Polyamide 66 ("PA66"), polybutylene terephthalate, ethanol, natural gas and fuel oil, and the prices for electricity and other energy sources; the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases; the possibility that we will not be able to realize the anticipated benefits of the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition"), including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities; additional impairments of goodwill or intangible assets; increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies; risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all; risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility; the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased price competition and the introduction of competing products by other companies; the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with the Company's strategy; market acceptance of our products and technology; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises, or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East) or terrorist incidents or as a result of weather, natural disasters, or other crises; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters; potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry, and the success of our deleveraging efforts, as well as any changes to our credit ratings; changes in currency exchange rates and interest rates; tax rates and changes thereto; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission.

    Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

    Non-GAAP Financial Measures

    Presentation

    This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.

    Use of Non-US GAAP Financial Information

    This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for operating EBITDA margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.

    Definitions of Non-US GAAP Financial Measures

    • Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8 of our Non-US GAAP Financial Measures and Supplemental Information document). We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales.

    • Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We do not provide reconciliations for operating EBITDA on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Operating EBITDA margin is defined by the Company as operating EBITDA divided by net sales.

    • Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.

      Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.

    • Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our noncontrolling interest joint ventures. We do not provide reconciliations for free cash flow on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of items such as working capital changes, fluctuations in foreign currency exchange rates, the impact and timing of potential acquisitions and divestitures, and other structural changes, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.

    Reconciliation of Non-US GAAP Financial Measures

    Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about August 11, 2025 and also available on our website at investors.celanese.com under Financial Information/Financial Document Library.

    Results Unaudited

    The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

    Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending June 30, 2025.

    Supplemental Information

    Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.

     

    Consolidated Statements of Operations - Unaudited

     

     

    Three Months Ended

     

    June 30,

    2025

     

    March 31,

    2025

     

    June 30,

    2024

     

     

    (In $ millions, except share and per share data)

    Net sales

     

    2,532

     

     

     

    2,389

     

     

     

    2,651

     

    Cost of sales

     

    (1,997

    )

     

     

    (1,913

    )

     

     

    (2,010

    )

    Gross profit

     

    535

     

     

     

    476

     

     

     

    641

     

    Selling, general and administrative expenses

     

    (213

    )

     

     

    (230

    )

     

     

    (255

    )

    Amortization of intangible assets

     

    (42

    )

     

     

    (40

    )

     

     

    (38

    )

    Research and development expenses

     

    (31

    )

     

     

    (31

    )

     

     

    (33

    )

    Other (charges) gains, net

     

    (20

    )

     

     

    (31

    )

     

     

    (48

    )

    Foreign exchange gain (loss), net

     

    6

     

     

     

    21

     

     

     

    (9

    )

    Gain (loss) on disposition of businesses and assets, net

     

    (2

    )

     

     

    3

     

     

     

    (8

    )

    Operating profit (loss)

     

    233

     

     

     

    168

     

     

     

    250

     

    Equity in net earnings (loss) of affiliates

     

    29

     

     

     

    22

     

     

     

    51

     

    Non-operating pension and other postretirement employee benefit (expense) income

     

    1

     

     

     

    2

     

     

     

    2

     

    Interest expense

     

    (177

    )

     

     

    (170

    )

     

     

    (174

    )

    Refinancing expense

     

    —

     

     

     

    (32

    )

     

     

    —

     

    Interest income

     

    7

     

     

     

    4

     

     

     

    10

     

    Dividend income - equity investments

     

    41

     

     

     

    1

     

     

     

    31

     

    Other income (expense), net

     

    1

     

     

     

    2

     

     

     

    13

     

    Earnings (loss) from continuing operations before tax

     

    135

     

     

     

    (3

    )

     

     

    183

     

    Income tax (provision) benefit

     

    77

     

     

     

    (9

    )

     

     

    (29

    )

    Earnings (loss) from continuing operations

     

    212

     

     

     

    (12

    )

     

     

    154

     

    Earnings (loss) from operation of discontinued operations

     

    (10

    )

     

     

    (6

    )

     

     

    (1

    )

    Income tax (provision) benefit from discontinued operations

     

    —

     

     

     

    1

     

     

     

    —

     

    Earnings (loss) from discontinued operations

     

    (10

    )

     

     

    (5

    )

     

     

    (1

    )

    Net earnings (loss)

     

    202

     

     

     

    (17

    )

     

     

    153

     

    Net (earnings) loss attributable to noncontrolling interests

     

    (3

    )

     

     

    (4

    )

     

     

    2

     

    Net earnings (loss) attributable to Celanese Corporation

     

    199

     

     

     

    (21

    )

     

     

    155

     

    Amounts attributable to Celanese Corporation

     

     

     

     

     

     

     

     

    Earnings (loss) from continuing operations

     

    209

     

     

     

    (16

    )

     

     

    156

     

    Earnings (loss) from discontinued operations

     

    (10

    )

     

     

    (5

    )

     

     

    (1

    )

    Net earnings (loss)

     

    199

     

     

     

    (21

    )

     

     

    155

     

    Earnings (loss) per common share - basic

     

     

     

     

     

     

     

     

    Continuing operations

     

    1.91

     

     

     

    (0.15

    )

     

     

    1.43

     

    Discontinued operations

     

    (0.09

    )

     

     

    (0.04

    )

     

     

    (0.01

    )

    Net earnings (loss) - basic

     

    1.82

     

     

     

    (0.19

    )

     

     

    1.42

     

    Earnings (loss) per common share - diluted

     

     

     

     

     

     

     

     

    Continuing operations

     

    1.90

     

     

     

    (0.15

    )

     

     

    1.42

     

    Discontinued operations

     

    (0.09

    )

     

     

    (0.04

    )

     

     

    (0.01

    )

    Net earnings (loss) - diluted

     

    1.81

     

     

     

    (0.19

    )

     

     

    1.41

     

    Weighted average shares (in millions)

     

     

     

     

     

     

     

     

    Basic

     

    109.5

     

     

     

    109.4

     

     

     

    109.3

     

    Diluted

     

    109.7

     

     

     

    109.4

     

     

     

    109.5

     

    Consolidated Balance Sheets - Unaudited

     

    As of

     

    As of

     

    June 30,

    2025

     

    December 31,

    2024

     

     

    (In $ millions)

     

    ASSETS

     

     

       

     

     

     

    Current Assets

     

     

       

     

     

     

    Cash and cash equivalents

     

    1,173

       

     

    962

     

    Trade receivables - third party and affiliates, net

     

    1,216

       

     

    1,121

     

    Non-trade receivables, net

     

    703

       

     

    493

     

    Inventories

     

    2,288

       

     

    2,284

     

    Other assets

     

    295

       

     

    285

     

    Total current assets

     

    5,675

       

     

    5,145

     

    Investments in affiliates

     

    1,263

       

     

    1,217

     

    Property, plant and equipment, net

     

    5,303

       

     

    5,273

     

    Operating lease right-of-use assets

     

    388

       

     

    388

     

    Deferred income taxes

     

    1,321

       

     

    1,251

     

    Other assets

     

    525

       

     

    555

     

    Goodwill

     

    5,466

       

     

    5,387

     

    Intangible assets, net

     

    3,772

       

     

    3,641

     

    Total assets

     

    23,713

       

     

    22,857

     

    LIABILITIES AND EQUITY

     

     

       

     

     

     

    Current Liabilities

     

     

       

     

     

     

    Short-term borrowings and current installments of long-term debt - third party and affiliates

     

    252

       

     

    1,501

     

    Trade payables - third party and affiliates

     

    1,283

       

     

    1,228

     

    Other liabilities

     

    1,137

       

     

    1,157

     

    Income taxes payable

     

    95

       

     

    4

     

    Total current liabilities

     

    2,767

       

     

    3,890

     

    Long-term debt, net of unamortized deferred financing costs

     

    12,689

       

     

    11,078

     

    Deferred income taxes

     

    704

       

     

    925

     

    Uncertain tax positions

     

    226

       

     

    286

     

    Benefit obligations

     

    411

       

     

    396

     

    Operating lease liabilities

     

    295

       

     

    294

     

    Other liabilities

     

    917

       

     

    408

     

    Commitments and Contingencies

     

     

       

     

     

     

    Shareholders' Equity

     

     

       

     

     

     

    Treasury stock, at cost

     

    (5,483)

       

     

    (5,486)

     

    Additional paid-in capital

     

    419

       

     

    409

     

    Retained earnings

     

    11,243

       

     

    11,071

     

    Accumulated other comprehensive income (loss), net

     

    (903)

       

     

    (848)

     

    Total Celanese Corporation shareholders' equity

     

    5,276

       

     

    5,146

     

    Noncontrolling interests

     

    428

       

     

    434

     

    Total equity

     

    5,704

       

     

    5,580

     

    Total liabilities and equity

     

    23,713

       

     

    22,857

     

    Non-US GAAP Financial Measures and Supplemental Information

    August 11, 2025

    In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.

    Purpose

    The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.

    Presentation

    This document presents the Company's two business segments, Engineered Materials and the Acetyl Chain.

    Use of Non-US GAAP Financial Measures

    From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.

    Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Financial Information/Financial Document Library page of our website, investors.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.

    Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Financial Information/Financial Document Library page of our website, investors.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.

    This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.

    Specific Measures Used

    This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation shareholders' equity.

    Definitions

    • Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as adjusted EBIT.
    • Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. We do not provide reconciliations for operating EBITDA on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Operating EBITDA margin is defined by the Company as operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as operating EBITDA.
    • Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as operating profit (loss) attributable to Celanese Corporation.
    • Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.



      Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
    • Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures. We believe that free cash flow provides useful information to management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations. Free cash flow is not a measure of cash available for discretionary expenditures since the Company has certain debt service and finance lease payments that are not deducted from that measure. We do not provide reconciliations for free cash flow on a forward-looking basis when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of items such as working capital changes, fluctuations in foreign currency exchange rates, the impact and timing of potential acquisitions and divestitures, and other structural changes, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
    • Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.
    • Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation shareholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our shareholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns.

    Supplemental Information

    Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:

    • Net sales for each of our business segments and the percentage increase or decrease in net sales attributable to price, volume, currency and other factors for each of our business segments.
    • Cash dividends received from our equity investments.
    • For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as NCI. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.

    Results Unaudited

    The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

    Certain prior period amounts have been revised to correct for certain prior period immaterial errors. See Note 1 to our Quarterly Report on Form 10-Q for the quarterly period ending June 30, 2025.

    Table 1

    Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions)

    Net earnings (loss) attributable to Celanese Corporation

    199

     

     

    (21

    )

     

    (1,531

    )

     

    (1,923

    )

     

    116

     

     

    155

     

     

    121

     

    (Earnings) loss from discontinued operations

    10

     

     

    5

     

     

    8

     

     

    5

     

     

    2

     

     

    1

     

     

    —

     

    Interest income

    (7

    )

     

    (4

    )

     

    (33

    )

     

    (5

    )

     

    (5

    )

     

    (10

    )

     

    (13

    )

    Interest expense

    177

     

     

    170

     

     

    676

     

     

    164

     

     

    169

     

     

    174

     

     

    169

     

    Refinancing expense

    —

     

     

    32

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

    Income tax provision (benefit)

    (77

    )

     

    9

     

     

    507

     

     

    384

     

     

    61

     

     

    29

     

     

    33

     

    Certain Items attributable to Celanese Corporation (Table 8)

    42

     

     

    43

     

     

    2,009

     

     

    1,696

     

     

    114

     

     

    102

     

     

    97

     

    Adjusted EBIT

    344

     

     

    234

     

     

    1,636

     

     

    321

     

     

    457

     

     

    451

     

     

    407

     

    Depreciation and amortization expense(1)

    188

     

     

    180

     

     

    728

     

     

    184

     

     

    187

     

     

    181

     

     

    176

     

    Operating EBITDA

    532

     

     

    414

     

     

    2,364

     

     

    505

     

     

    644

     

     

    632

     

     

    583

     

     

     

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions)

    Engineered Materials

    2

     

     

    —

     

     

    73

     

     

    1

     

     

    16

     

     

    11

     

     

    45

     

    Acetyl Chain

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

    Other Activities(2)

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

    Accelerated depreciation and amortization expense

    2

     

     

    —

     

     

    73

     

     

    1

     

     

    16

     

     

    11

     

     

    45

     

    Depreciation and amortization expense(1)

    188

     

     

    180

     

     

    728

     

     

    184

     

     

    187

     

     

    181

     

     

    176

     

    Total depreciation and amortization expense

    190

     

     

    180

     

     

    801

     

     

    185

     

     

    203

     

     

    192

     

     

    221

     

    ______________________________

    (1)

    Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.

    (2)

    Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

    Table 2

    Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited

     

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions, except percentages)

    Operating Profit (Loss) / Operating Margin

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    165

     

     

    11.4

    %

     

    96

     

     

    7.5

    %

     

    (1,191

    )

     

    (21.3

    )%

     

    (1,520

    )

     

    (119.8

    )%

     

    102

     

     

    6.9

    %

     

    138

     

     

    9.4

    %

     

    89

     

     

    6.5

    %

    Acetyl Chain

    154

     

     

    13.8

    %

     

    162

     

     

    14.5

    %

     

    951

     

     

    20.0

    %

     

    216

     

     

    19.5

    %

     

    239

     

     

    20.1

    %

     

    242

     

     

    20.1

    %

     

    254

     

     

    20.1

    %

    Other Activities(1)

    (86

    )

     

     

     

    (90

    )

     

     

     

    (469

    )

     

     

     

    (113

    )

     

     

     

    (93

    )

     

     

     

    (130

    )

     

     

     

    (133

    )

     

     

    Total

    233

     

     

    9.2

    %

     

    168

     

     

    7.0

    %

     

    (709

    )

     

    (6.9

    )%

     

    (1,417

    )

     

    (60.1

    )%

     

    248

     

     

    9.4

    %

     

    250

     

     

    9.4

    %

     

    210

     

     

    8.0

    %

    Less: Net Earnings (Loss) Attributable to NCI for Engineered Materials

    1

     

     

     

     

    2

     

     

     

     

    (1

    )

     

     

     

    2

     

     

     

     

    2

     

     

     

     

    (4

    )

     

     

     

    (1

    )

     

     

    Less: Net Earnings (Loss) Attributable to NCI for Acetyl Chain

    2

     

     

     

     

    2

     

     

     

     

    9

     

     

     

     

    1

     

     

     

     

    2

     

     

     

     

    2

     

     

     

     

    4

     

     

     

    Operating Profit (Loss) Attributable to Celanese Corporation

    230

     

     

    9.1

    %

     

    164

     

     

    6.9

    %

     

    (717

    )

     

    (7.0

    )%

     

    (1,420

    )

     

    (60.2

    )%

     

    244

     

     

    9.2

    %

     

    252

     

     

    9.5

    %

     

    207

     

     

    7.9

    %

    Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    164

     

     

    11.4

    %

     

    94

     

     

    7.3

    %

     

    (1,190

    )

     

    (21.3

    )%

     

    (1,522

    )

     

    (119.9

    )%

     

    100

     

     

    6.8

    %

     

    142

     

     

    9.7

    %

     

    90

     

     

    6.5

    %

    Acetyl Chain

    152

     

     

    13.6

    %

     

    160

     

     

    14.3

    %

     

    942

     

     

    19.8

    %

     

    215

     

     

    19.4

    %

     

    237

     

     

    19.9

    %

     

    240

     

     

    20.0

    %

     

    250

     

     

    19.8

    %

    Other Activities(1)

    (86

    )

     

     

     

    (90

    )

     

     

     

    (469

    )

     

     

     

    (113

    )

     

     

     

    (93

    )

     

     

     

    (130

    )

     

     

     

    (133

    )

     

     

    Total

    230

     

     

    9.1

    %

     

    164

     

     

    6.9

    %

     

    (717

    )

     

    (7.0

    )%

     

    (1,420

    )

     

    (60.2

    )%

     

    244

     

     

    9.2

    %

     

    252

     

     

    9.5

    %

     

    207

     

     

    7.9

    %

    Equity Earnings and Dividend Income, Other Income (Expense) Attributable to Celanese Corporation

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    25

     

     

     

     

    17

     

     

     

     

    178

     

     

     

     

    33

     

     

     

     

    46

     

     

     

     

    49

     

     

     

     

    50

     

     

     

    Acetyl Chain

    43

     

     

     

     

    3

     

     

     

     

    138

     

     

     

     

    35

     

     

     

     

    34

     

     

     

     

    33

     

     

     

     

    36

     

     

     

    Other Activities(1)

    3

     

     

     

     

    5

     

     

     

     

    48

     

     

     

     

    4

     

     

     

     

    16

     

     

     

     

    13

     

     

     

     

    15

     

     

     

    Total

    71

     

     

     

     

    25

     

     

     

     

    364

     

     

     

     

    72

     

     

     

     

    96

     

     

     

     

    95

     

     

     

     

    101

     

     

     

    Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    —

     

     

     

     

    —

     

     

     

     

    8

     

     

     

     

    8

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

    Acetyl Chain

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

    Other Activities(1)

    1

     

     

     

     

    2

     

     

     

     

    (28

    )

     

     

     

    (35

    )

     

     

     

    3

     

     

     

     

    2

     

     

     

     

    2

     

     

     

    Total

    1

     

     

     

     

    2

     

     

     

     

    (20

    )

     

     

     

    (27

    )

     

     

     

    3

     

     

     

     

    2

     

     

     

     

    2

     

     

     

    Certain Items Attributable to Celanese Corporation (Table 8)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    25

     

     

     

     

    15

     

     

     

     

    1,851

     

     

     

     

    1,625

     

     

     

     

    91

     

     

     

     

    74

     

     

     

     

    61

     

     

     

    Acetyl Chain

    1

     

     

     

     

    5

     

     

     

     

    22

     

     

     

     

    3

     

     

     

     

    5

     

     

     

     

    4

     

     

     

     

    10

     

     

     

    Other Activities(1)

    16

     

     

     

     

    23

     

     

     

     

    136

     

     

     

     

    68

     

     

     

     

    18

     

     

     

     

    24

     

     

     

     

    26

     

     

     

    Total

    42

     

     

     

     

    43

     

     

     

     

    2,009

     

     

     

     

    1,696

     

     

     

     

    114

     

     

     

     

    102

     

     

     

     

    97

     

     

     

    Adjusted EBIT / Adjusted EBIT Margin

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    214

     

     

    14.8

    %

     

    126

     

     

    9.8

    %

     

    847

     

     

    15.1

    %

     

    144

     

     

    11.3

    %

     

    237

     

     

    16.0

    %

     

    265

     

     

    18.1

    %

     

    201

     

     

    14.6

    %

    Acetyl Chain

    196

     

     

    17.6

    %

     

    168

     

     

    15.1

    %

     

    1,102

     

     

    23.1

    %

     

    253

     

     

    22.8

    %

     

    276

     

     

    23.2

    %

     

    277

     

     

    23.0

    %

     

    296

     

     

    23.5

    %

    Other Activities(1)

    (66

    )

     

     

     

    (60

    )

     

     

     

    (313

    )

     

     

     

    (76

    )

     

     

     

    (56

    )

     

     

     

    (91

    )

     

     

     

    (90

    )

     

     

    Total

    344

     

     

    13.6

    %

     

    234

     

     

    9.8

    %

     

    1,636

     

     

    15.9

    %

     

    321

     

     

    13.6

    %

     

    457

     

     

    17.3

    %

     

    451

     

     

    17.0

    %

     

    407

     

     

    15.6

    %

    ___________________________

    (1)

    Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

    Table 2

    Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)

     

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions, except percentages)

    Depreciation and Amortization Expense(1)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    112

     

     

     

     

    109

     

     

     

     

    437

     

     

     

     

    114

     

     

     

     

    111

     

     

     

     

    110

     

     

     

     

    102

     

     

     

    Acetyl Chain

    64

     

     

     

     

    61

     

     

     

     

    244

     

     

     

     

    63

     

     

     

     

    63

     

     

     

     

    61

     

     

     

     

    57

     

     

     

    Other Activities(2)

    12

     

     

     

     

    10

     

     

     

     

    47

     

     

     

     

    7

     

     

     

     

    13

     

     

     

     

    10

     

     

     

     

    17

     

     

     

    Total

    188

     

     

     

     

    180

     

     

     

     

    728

     

     

     

     

    184

     

     

     

     

    187

     

     

     

     

    181

     

     

     

     

    176

     

     

     

    Operating EBITDA / Operating EBITDA Margin

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Engineered Materials

    326

     

     

    22.6

    %

     

    235

     

     

    18.3

    %

     

    1,284

     

     

    22.9

    %

     

    258

     

     

    20.3

    %

     

    348

     

     

    23.5

    %

     

    375

     

     

    25.6

    %

     

    303

     

     

    22.0

    %

    Acetyl Chain

    260

     

     

    23.3

    %

     

    229

     

     

    20.5

    %

     

    1,346

     

     

    28.3

    %

     

    316

     

     

    28.5

    %

     

    339

     

     

    28.5

    %

     

    338

     

     

    28.1

    %

     

    353

     

     

    28.0

    %

    Other Activities(2)

    (54

    )

     

     

     

    (50

    )

     

     

     

    (266

    )

     

     

     

    (69

    )

     

     

     

    (43

    )

     

     

     

    (81

    )

     

     

     

    (73

    )

     

     

    Total

    532

     

     

    21.0

    %

     

    414

     

     

    17.3

    %

     

    2,364

     

     

    23.0

    %

     

    505

     

     

    21.4

    %

     

    644

     

     

    24.3

    %

     

    632

     

     

    23.8

    %

     

    583

     

     

    22.3

    %

    ___________________________

    (1)

    Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.

    (2)

    Other Activities includes corporate SG&A expenses, results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

    Table 3

    Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited

     

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

     

     

    per

    share

     

     

     

    per

    share

     

     

     

    per

    share

     

     

     

    per

    share

     

     

     

    per

    share

     

     

     

    per

    share

     

     

     

    per

    share

     

    (In $ millions, except per share data)

    Earnings (loss) from continuing operations attributable to Celanese Corporation

    209

     

     

    1.90

     

    (16

    )

     

    (0.15

    )

     

    (1,523

    )

     

    (13.94

    )

     

    (1,918

    )

     

    (17.54

    )

     

    118

     

     

    1.08

     

    156

     

     

    1.42

     

    121

     

     

    1.10

    Income tax provision (benefit)

    (77

    )

     

     

     

    9

     

     

     

     

    507

     

     

     

     

    384

     

     

     

     

    61

     

     

     

     

    29

     

     

     

     

    33

     

     

     

    Earnings (loss) from continuing operations before tax

    132

     

     

     

     

    (7

    )

     

     

     

    (1,016

    )

     

     

     

    (1,534

    )

     

     

     

    179

     

     

     

     

    185

     

     

     

     

    154

     

     

     

    Certain Items attributable to Celanese Corporation (Table 8)

    42

     

     

     

     

    43

     

     

     

     

    2,009

     

     

     

     

    1,696

     

     

     

     

    114

     

     

     

     

    102

     

     

     

     

    97

     

     

     

    Refinancing and related expenses

    —

     

     

     

    32

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

    Adjusted earnings (loss) from continuing operations before tax

    174

     

     

     

     

    68

     

     

     

     

    993

     

     

     

     

    162

     

     

     

     

    293

     

     

     

     

    287

     

     

     

     

    251

     

     

     

    Income tax (provision) benefit on adjusted earnings(1)

    (16

    )

     

     

     

    (6

    )

     

     

     

    (89

    )

     

     

     

    (14

    )

     

     

     

    (26

    )

     

     

     

    (26

    )

     

     

     

    (23

    )

     

     

    Adjusted earnings (loss) from continuing operations(2)

    158

     

     

    1.44

     

    62

     

     

    0.57

     

     

    904

     

     

    8.27

     

     

    148

     

     

    1.35

     

     

    267

     

     

    2.44

     

    261

     

     

    2.38

     

    228

     

     

    2.08

    Diluted shares (in millions)(3)

    Weighted average shares outstanding

    109.5

     

     

     

     

    109.4

     

     

     

     

    109.3

     

     

     

     

    109.4

     

     

     

     

    109.3

     

     

     

     

    109.3

     

     

     

     

    109.1

     

     

     

    Incremental shares attributable to equity awards

    0.2

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    —

     

     

     

     

    0.2

     

     

     

     

    0.2

     

     

     

     

    0.4

     

     

     

    Total diluted shares

    109.7

     

     

     

     

    109.4

     

     

     

     

    109.3

     

     

     

     

    109.4

     

     

     

     

    109.5

     

     

     

     

    109.5

     

     

     

     

    109.5

     

     

     

     

    ______________________________

    (1) Calculated using adjusted effective tax rates (Table 3a) as follows:

     

    Q2 '25

     

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

     

    Q2 '24

     

    Q1 '24

     

    Adjusted effective tax rate

    9

    9

    9

    9

    9

    9

    9

     
    (2) Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.

     

    Actual Plan

    Asset Returns

     

    Expected

    Plan Asset

    Returns

     

     

    (In percentages)

    2024

     

    2.5

     

    5.3

    (3)

    Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.

    Table 3a

    Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited

     

    Estimated

     

    Actual

     

    2025

     

     

    2024

     

     

    (In percentages)

    US GAAP annual effective tax rate

    2

     

     

    (50

    )

    Discrete quarterly recognition of GAAP items(1)

    7

     

     

    1

     

    Tax impact of other charges and adjustments(2)

    (2

    )

     

    98

     

    Changes in valuation allowances, excluding impact of other charges and adjustments(3)

    (6

    )

     

    (40

    )

    Other, includes effect of discrete current year transactions(4)

    8

     

     

    —

     

    Adjusted tax rate

    9

     

     

    9

     

    ______________________________

    Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results.

    (1)

    Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.

    (2)

    Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.

    (3)

    Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.

    (4)

    Includes tax impacts related to full-year actual tax opportunities and related costs, as well as current year realization of U.S. GAAP benefits deferred in prior years.

    Table 4

    Net Sales by Segment - Unaudited

     

    Q2 '25

     

    Q1 '25

     

    2024

     

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions)

    Engineered Materials

    1,442

     

     

    1,287

     

     

    5,595

     

     

    1,269

     

     

    1,481

     

     

    1,467

     

     

    1,378

     

    Acetyl Chain

    1,115

     

     

    1,116

     

     

    4,763

     

     

    1,110

     

     

    1,190

     

     

    1,202

     

     

    1,261

     

    Intersegment eliminations(1)

    (25

    )

     

    (14

    )

     

    (90

    )

     

    (21

    )

     

    (23

    )

     

    (18

    )

     

    (28

    )

    Net sales

    2,532

     

     

    2,389

     

     

    10,268

     

     

    2,358

     

     

    2,648

     

     

    2,651

     

     

    2,611

     

    ___________________________

    (1)

    Includes intersegment sales primarily related to the Acetyl Chain.

    Table 4a

    Factors Affecting Segment Net Sales Sequentially - Unaudited

    Three Months Ended June 30, 2025 Compared to Three Months Ended March 31, 2025

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    9

     

     

    —

     

     

    3

     

    12

     

    Acetyl Chain

    (1

    )

     

    (2

    )

     

    3

     

    —

     

     

     

     

     

     

     

     

     

     

    Total Company

    4

     

     

    (1

    )

     

    3

     

    6

     

    Three Months Ended March 31, 2025 Compared to Three Months Ended December 31, 2024

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    —

     

    2

     

     

    (1

    )

     

    1

     

    Acetyl Chain

    3

     

    (1

    )

     

    (1

    )

     

    1

     

     

     

     

     

     

     

     

     

     

    Total Company

    2

     

    —

     

     

    (1

    )

     

    1

     

    Three Months Ended December 31, 2024 Compared to Three Months Ended September 30, 2024

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (10

    )

     

    (3

    )

     

    (1

    )

     

    (14

    )

     

    Acetyl Chain

    (4

    )

     

    (2

    )

     

    (1

    )

     

    (7

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    (7

    )

     

    (3

    )

     

    (1

    )

     

    (11

    )

     

    Three Months Ended September 30, 2024 Compared to Three Months Ended June 30, 2024

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    —

     

    —

     

     

    1

     

    1

     

     

    Acetyl Chain

    —

     

    (2

    )

     

    1

     

    (1

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    —

     

    (1

    )

     

    1

     

    —

     

     

    Three Months Ended June 30, 2024 Compared to Three Months Ended March 31, 2024

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    7

     

     

    —

     

     

    (1

    )

     

    6

     

     

    Acetyl Chain

    (1

    )

     

    (4

    )

     

    —

     

     

    (5

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    4

     

     

    (2

    )

     

    —

     

     

    2

     

     

    Three Months Ended March 31, 2024 Compared to Three Months Ended December 31, 2023

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (1

    )

     

    —

     

    —

     

    (1

    )

     

    Acetyl Chain

    5

     

     

    1

     

    1

     

    7

     

     

     

     

     

     

     

     

     

     

     

    Total Company

    1

     

     

    1

     

    —

     

    2

     

     

    Table 4b

    Factors Affecting Segment Net Sales Year Over Year - Unaudited

    Three Months Ended June 30, 2025 Compared to Three Months Ended June 30, 2024

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (3

    )

     

    (1

    )

     

    2

     

    (2

    )

     

    Acetyl Chain

    (2

    )

     

    (7

    )

     

    2

     

    (7

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    (2

    )

     

    (4

    )

     

    2

     

    (4

    )

     

    Three Months Ended March 31, 2025 Compared to Three Months Ended March 31, 2024

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (4

    )

     

    (2

    )

     

    (1

    )

     

    (7

    )

     

    Acetyl Chain

    (6

    )

     

    (4

    )

     

    (1

    )

     

    (11

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    (5

    )

     

    (3

    )

     

    (1

    )

     

    (9

    )

     

    Three Months Ended December 31, 2024 Compared to Three Months Ended December 31, 2023

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (6

    )

     

    (3

    )

     

    —

     

    (9

    )

     

    Acetyl Chain

    (2

    )

     

    (4

    )

     

    —

     

    (6

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    (4

    )

     

    (4

    )

     

    —

     

    (8

    )

     

    Three Months Ended September 30, 2024 Compared to Three Months Ended September 30, 2023

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (1

    )

     

    (2

    )

     

    —

     

    (3

    )

     

    Acetyl Chain

    1

     

     

    (3

    )

     

    —

     

    (2

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    —

     

     

    (3

    )

     

    —

     

    (3

    )

     

    Three Months Ended June 30, 2024 Compared to Three Months Ended June 30, 2023

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (2

    )

     

    (4

    )

     

    (1

    )

     

    (7

    )

     

    Acetyl Chain

    4

     

     

    (6

    )

     

    (1

    )

     

    (3

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    1

     

     

    (5

    )

     

    (1

    )

     

    (5

    )

     

    Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (12

    )

     

    (2

    )

     

    (1

    )

     

    (15

    )

     

    Acetyl Chain

    11

     

     

    (10

    )

     

    —

     

     

    1

     

     

     

     

     

     

     

     

     

     

     

    Total Company

    (2

    )

     

    (5

    )

     

    (1

    )

     

    (8

    )

     

    Table 4c

    Factors Affecting Segment Net Sales Year Over Year - Unaudited

    Year Ended December 31, 2024 Compared to Year Ended December 31, 2023

     

    Volume

     

    Price

     

    Currency

     

    Total

     

     

    (In percentages)

     

    Engineered Materials

    (5

    )

     

    (3

    )

     

    (1

    )

     

    (9

    )

     

    Acetyl Chain

    4

     

     

    (6

    )

     

    —

     

     

    (2

    )

     

     

     

     

     

     

     

     

     

     

    Total Company

    (1

    )

     

    (4

    )

     

    (1

    )

     

    (6

    )

     

    Table 5

    Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited

     

    Q2 '25

     

    Q1 '25

     

    2024

     

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions, except percentages)

    Net cash provided by (used in) investing activities

    (88

    )

     

    (98

    )

     

    (470

    )

     

    (128

    )

     

    (100

    )

     

    (91

    )

     

    (151

    )

    Net cash provided by (used in) financing activities

    (116

    )

     

    45

     

     

    (1,313

    )

     

    (189

    )

     

    (376

    )

     

    (489

    )

     

    (259

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net cash provided by (used in) operating activities

    410

     

     

    37

     

     

    966

     

     

    494

     

     

    79

     

     

    292

     

     

    101

     

    Capital expenditures on property, plant and equipment

    (93

    )

     

    (102

    )

     

    (435

    )

     

    (105

    )

     

    (88

    )

     

    (105

    )

     

    (137

    )

    Contributions from/(Distributions) to NCI

    (6

    )

     

    (8

    )

     

    (33

    )

     

    (8

    )

     

    (7

    )

     

    (14

    )

     

    (4

    )

    Free cash flow(1)

    311

     

     

    (73

    )

     

    498

     

     

    381

     

     

    (16

    )

     

    173

     

     

    (40

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net sales

    2,532

     

     

    2,389

     

     

    10,268

     

     

    2,358

     

     

    2,648

     

     

    2,651

     

     

    2,611

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Free cash flow as % of Net sales

    12.3

    %

     

    (3.1

    )%

     

    4.9

    %

     

    16.2

    %

     

    (0.6

    )%

     

    6.5

    %

     

    (1.5

    )%

    ______________________________

    (1)

    Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for contributions from or distributions to our NCI joint ventures.

    Table 6

    Cash Dividends Received - Unaudited

     

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions)

    Dividends from equity method investments

    21

     

    31

     

    160

     

    38

     

    26

     

    69

     

    27

    Dividends from equity investments without readily determinable fair values

    41

     

    1

     

    128

     

    33

     

    30

     

    31

     

    34

    Total

    62

     

    32

     

    288

     

    71

     

    56

     

    100

     

    61

    Table 7

    Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited

     

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    (In $ millions)

    Short-term borrowings and current installments of long-term debt - third party and affiliates

    252

     

     

    406

     

     

    1,501

     

     

    1,501

     

     

    1,607

     

     

    1,977

     

     

    2,439

     

    Long-term debt, net of unamortized deferred financing costs

    12,689

     

     

    12,378

     

     

    11,078

     

     

    11,078

     

     

    11,324

     

     

    11,058

     

     

    11,018

     

    Total debt

    12,941

     

     

    12,784

     

     

    12,579

     

     

    12,579

     

     

    12,931

     

     

    13,035

     

     

    13,457

     

    Cash and cash equivalents

    (1,173

    )

     

    (951

    )

     

    (962

    )

     

    (962

    )

     

    (813

    )

     

    (1,185

    )

     

    (1,483

    )

    Net debt

    11,768

     

     

    11,833

     

     

    11,617

     

     

    11,617

     

     

    12,118

     

     

    11,850

     

     

    11,974

     

    Table 8

    Certain Items - Unaudited

    The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:

     

    Q2 '25

     

    Q1 '25

     

    2024

     

    Q4 '24

     

    Q3 '24

     

    Q2 '24

     

    Q1 '24

     

    Income Statement Classification

     

    (In $ millions)

     

     

    Exit and shutdown costs

    27

     

    32

     

    236

     

    47

     

    52

     

    69

     

    68

     

    Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Non-operating pension and other postretirement employee benefit (expense) income

    Asset impairments

    —

     

    —

     

    1,638

     

    1,601

    (1)

    34

    (2)

    3

     

    —

     

    Cost of sales / Other (charges) gains, net

    Impact from plant incidents and natural disasters

    —

     

    3

     

    13

     

    3

     

    3

     

    —

     

    7

     

    Cost of sales

    Mergers, acquisitions and dispositions

    12

     

    5

     

    80

     

    12

     

    17

     

    26

     

    25

     

    Cost of sales / SG&A

    Actuarial (gain) loss on pension and postretirement plans

    —

     

    —

     

    27

     

    27

     

    —

     

    —

     

    —

     

    Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income

    Legal settlements and commercial disputes

    2

     

    3

     

    8

     

    6

     

    7

     

    3

     

    (8)

     

    Cost of sales / SG&A / Other (charges) gains, net

    (Gain) loss on disposition of businesses and assets

    —

     

    —

     

    2

     

    —

     

    1

     

    1

     

    —

     

    Gain (loss) on disposition of businesses and assets, net

    Other

    1

     

    —

     

    5

     

    —

     

    —

     

    —

     

    5

     

    Cost of sales / SG&A

    Certain Items attributable to Celanese Corporation

    42

     

    43

     

    2,009

     

    1,696

     

    114

     

    102

     

    97

     

     

    ___________________________

    (1)

    Related to impairment of goodwill and certain trade names, primarily Zytel®, arising from our interim goodwill and indefinite-lived intangible assets impairment tests.

    (2)

    Related to impairment of certain tradenames, primarily Zytel®, in connection with our annual goodwill and indefinite-lived intangible asset impairment tests.

    Table 9

    Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited

     

     

     

     

     

    2024

     

     

     

     

     

    (In $ millions, except

    percentages)

    Net earnings (loss) attributable to Celanese Corporation

     

     

     

     

    (1,531

    )

     

     

     

     

     

     

    Adjusted EBIT (Table 1)

     

     

     

     

    1,636

     

    Adjusted effective tax rate (Table 3a)

     

     

     

     

    9

    %

    Adjusted EBIT tax effected

     

     

     

     

    1,489

     

     

     

     

     

     

     

     

    2024

     

    2023

     

    Average

     

    (In $ millions, except percentages)

    Short-term borrowings and current installments of long-term debt - third parties and affiliates

    1,501

     

    1,383

     

    1,442

     

    Long-term debt, net of unamortized deferred financing costs

    11,078

     

    12,301

     

    11,690

     

    Celanese Corporation shareholders' equity

    5,146

     

    7,071

     

    6,109

     

    Invested capital

     

     

     

     

    19,241

     

     

     

     

     

     

     

    Return on invested capital (adjusted)

     

     

     

     

    7.7

    %

     

     

     

     

     

     

    Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital

     

     

     

     

    (8.0

    )%

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250807354247/en/

    Investor Relations

    Bill Cunningham

    Phone: +1 302 772 5231

    [email protected]

    Media - U.S.

    Jamaison Schuler

    Phone: +1 972 443 4400

    [email protected]

    Media - Europe

    Petra Czugler

    Phone: +49 69 45009 1206

    [email protected]

    Get the next $CE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CE

    DatePrice TargetRatingAnalyst
    6/16/2025$66.00Equal Weight → Overweight
    Wells Fargo
    5/20/2025$55.00Underperform → Market Perform
    BMO Capital Markets
    3/21/2025$76.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/17/2025$70.00Neutral → Overweight
    Alembic Global Advisors
    3/6/2025$66.00Sell → Hold
    Vertical Research
    2/20/2025$84.00 → $56.00Outperform → Sector Perform
    RBC Capital Mkts
    1/14/2025$95.00 → $88.00Underperform → Buy
    BofA Securities
    11/11/2024$161.00 → $97.00Buy → Neutral
    UBS
    More analyst ratings

    $CE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Celanese upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Celanese from Equal Weight to Overweight and set a new price target of $66.00

    6/16/25 7:41:22 AM ET
    $CE
    Major Chemicals
    Industrials

    Celanese upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Celanese from Underperform to Market Perform and set a new price target of $55.00

    5/20/25 8:01:00 AM ET
    $CE
    Major Chemicals
    Industrials

    Celanese upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Celanese from Sector Weight to Overweight and set a new price target of $76.00

    3/21/25 8:01:25 AM ET
    $CE
    Major Chemicals
    Industrials

    $CE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Celanese Corporation Announces New $1.75 Billion Revolving Credit Facility

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced that it has entered into a new credit agreement ("Agreement") effective August 11, 2025 which includes a new $1.75 billion senior unsecured revolving credit facility, replacing the Company's previous revolving credit facility of the same size which was set to mature in March of 2027. The new revolving credit facility matures in August of 2030. "This Agreement demonstrates our ongoing commitment to proactively and opportunistically manage Celanese's debt and liquidity profile," said Chuck Kyrish, Senior Vice President and Chief Financial Officer. "We are pleased to have the support of our ban

    8/11/25 4:33:00 PM ET
    $CE
    Major Chemicals
    Industrials

    Celanese Corporation Reports Second Quarter Earnings

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today reported second quarter 2025 U.S. GAAP diluted earnings per share of $1.90 and adjusted earnings per share of $1.44. The Company generated net sales of $2.5 billion in the second quarter, a 6 percent increase from the previous quarter driven by increases of 4 percent in volume and 3 percent in currency, with a small offset in price. Most end-markets continued to be challenged in the second quarter, and Celanese remained focused on driving self-help measures to advance the strategic priorities of increasing cash to deleverage the balance sheet, intensifying cost improvements, and driving top-line growth

    8/11/25 4:05:00 PM ET
    $CE
    Major Chemicals
    Industrials

    Bentley Mills Becomes Early Adopter of Celanese ECO-CC Binder To Advance Sustainable Carpet Tile Manufacturing

    Bentley integrates innovative carbon capture technology into production process Celanese Corporation (NYSE:CE), a global specialty materials and chemical company, and Bentley Mills, a leading commercial carpet manufacturer, announced today that Bentley is one of the first users of Celanese's vinyl acetate ethylene (VAE) ECO-CC emulsions, a binder made with raw materials derived from captured carbon dioxide (CO₂), for Bentley's carpet tile production. VAE ECO-CC emulsion is produced using carbon capture and utilization (CCU) based raw materials from the Celanese Clear Lake, Texas site. By capturing and using carbon dioxide (CO₂) as a raw material for binder production instead of virgin f

    7/29/25 9:03:00 AM ET
    $CE
    Major Chemicals
    Industrials

    $CE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP - Acetyls Murray Mark Christopher bought $84,371 worth of shares (2,017 units at $41.83), increasing direct ownership by 13% to 17,000 units (SEC Form 4)

    4 - Celanese Corp (0001306830) (Issuer)

    8/18/25 4:02:22 PM ET
    $CE
    Major Chemicals
    Industrials

    Director Sutton Scott Mcdougald bought $81,787 worth of shares (2,000 units at $40.89), increasing direct ownership by 11% to 20,376 units (SEC Form 4)

    4 - Celanese Corp (0001306830) (Issuer)

    8/18/25 4:01:59 PM ET
    $CE
    Major Chemicals
    Industrials

    Director Moorthy Ganesh bought $40,942 worth of shares (1,000 units at $40.94), increasing direct ownership by 20% to 6,015 units (SEC Form 4)

    4 - Celanese Corp (0001306830) (Issuer)

    8/18/25 4:01:36 PM ET
    $CE
    Major Chemicals
    Industrials

    $CE
    SEC Filings

    View All

    Celanese Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Celanese Corp (0001306830) (Filer)

    8/11/25 5:30:39 PM ET
    $CE
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Celanese Corporation

    10-Q - Celanese Corp (0001306830) (Filer)

    8/11/25 4:36:44 PM ET
    $CE
    Major Chemicals
    Industrials

    Celanese Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Celanese Corp (0001306830) (Filer)

    8/11/25 4:27:19 PM ET
    $CE
    Major Chemicals
    Industrials

    $CE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP - Acetyls Murray Mark Christopher bought $84,371 worth of shares (2,017 units at $41.83), increasing direct ownership by 13% to 17,000 units (SEC Form 4)

    4 - Celanese Corp (0001306830) (Issuer)

    8/18/25 4:02:22 PM ET
    $CE
    Major Chemicals
    Industrials

    Director Sutton Scott Mcdougald bought $81,787 worth of shares (2,000 units at $40.89), increasing direct ownership by 11% to 20,376 units (SEC Form 4)

    4 - Celanese Corp (0001306830) (Issuer)

    8/18/25 4:01:59 PM ET
    $CE
    Major Chemicals
    Industrials

    Director Moorthy Ganesh bought $40,942 worth of shares (1,000 units at $40.94), increasing direct ownership by 20% to 6,015 units (SEC Form 4)

    4 - Celanese Corp (0001306830) (Issuer)

    8/18/25 4:01:36 PM ET
    $CE
    Major Chemicals
    Industrials

    $CE
    Financials

    Live finance-specific insights

    View All

    Celanese Corporation Reports Second Quarter Earnings

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today reported second quarter 2025 U.S. GAAP diluted earnings per share of $1.90 and adjusted earnings per share of $1.44. The Company generated net sales of $2.5 billion in the second quarter, a 6 percent increase from the previous quarter driven by increases of 4 percent in volume and 3 percent in currency, with a small offset in price. Most end-markets continued to be challenged in the second quarter, and Celanese remained focused on driving self-help measures to advance the strategic priorities of increasing cash to deleverage the balance sheet, intensifying cost improvements, and driving top-line growth

    8/11/25 4:05:00 PM ET
    $CE
    Major Chemicals
    Industrials

    Celanese Corporation Declares Quarterly Dividend of $0.03 Per Share

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today declared a quarterly cash dividend of $0.03 per share on its common stock, payable August 11, 2025. The dividend is payable to stockholders of record as of July 29, 2025. About Celanese Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer an

    7/16/25 4:15:00 PM ET
    $CE
    Major Chemicals
    Industrials

    Celanese to Hold Second Quarter Earnings Conference Call on August 12, 2025

    Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced that it will host a conference call to discuss its second quarter 2025 results on Tuesday, August 12, 2025, beginning at 9:00 a.m. ET. The conference call will be available by webcast at https://investors.celanese.com or by phone: Dial-in Number: 1-877-407-0989 International Dial-In Number: 1-201-389-0921 Alternatively, to enter the call immediately without waiting for operator assistance, attendees may pre-register for the call by clicking the link below. Registrant Link: http://services.incommconferencing.com/DiamondPassRegistration/register?confirmationNumber=13754713&linkSecuritySt

    7/7/25 4:00:00 PM ET
    $CE
    Major Chemicals
    Industrials

    $CE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Celanese Corporation

    SC 13G/A - Celanese Corp (0001306830) (Subject)

    12/6/24 12:11:25 PM ET
    $CE
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Celanese Corporation

    SC 13G/A - Celanese Corp (0001306830) (Subject)

    12/5/24 2:20:23 PM ET
    $CE
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Celanese Corporation

    SC 13G/A - Celanese Corp (0001306830) (Subject)

    11/13/24 12:52:42 PM ET
    $CE
    Major Chemicals
    Industrials

    $CE
    Leadership Updates

    Live Leadership Updates

    View All

    DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

    3/7/25 6:19:00 PM ET
    $ALK
    $AMBC
    $ATI
    Air Freight/Delivery Services
    Consumer Discretionary
    Property-Casualty Insurers
    Finance

    Scott Sutton Elected to Celanese Board of Directors

    Board Establishes Finance and Business Review Committee to Assist with Oversight of the Company's Financial Position and Business Improvement Initiatives Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced the election of Scott Sutton to the company's Board of Directors. Mr. Sutton, 60, will join the Celanese Board effective March 1, 2025, and stand for re-election at the 2025 Annual Meeting of Shareholders. In addition, the Board has established a Finance and Business Review Committee, to assist with oversight of the company's financial position and strategy, including its efforts to further reduce costs, prioritize cash flow, accelerate del

    2/14/25 9:15:00 AM ET
    $CE
    Major Chemicals
    Industrials

    Celanese Announces New Leadership Appointment to Drive Growth and Profitability

    Todd Elliott Rejoins Celanese to Lead Engineered Materials Celanese Corporation (NYSE:CE), a global chemical and specialty materials company, today announced a new addition to its Executive Leadership Team (ELT). Todd Elliott, a proven executive who retired from Celanese in 2020 as Senior Vice President (SVP) and head of the Acetyls business, will return to the Company as SVP to lead the Engineered Materials (EM) business, effective February 3, 2025. Elliott will succeed Tom Kelly, who is stepping down as SVP, Engineered Materials and will serve in a transition role through March 10, 2025. Elliott had a diverse and successful career with Celanese, progressing through multiple leadersh

    1/16/25 4:15:00 PM ET
    $CE
    Major Chemicals
    Industrials